SCHEMBL4154581

SCHEMBL4154581

CCOC(=O)c1nccc(C2=C(c3cc(Cl)ccc3OC)CCC2)c1Cl

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PTGER1 P34995 5/20 0.43
GABRG2 P18507 3/20 0.43
GABRB3 P28472 3/20 0.43
GABRA5 P31644 3/20 0.43
GABRA1 P14867 1/20 0.43
GABRA3 P34903 1/20 0.43
GABRA2 P47869 1/20 0.43
GABRB2 P47870 1/20 0.43
GABRA4 P48169 1/20 0.43
GABRA6 Q16445 1/20 0.43
CYP2C9 P11712 2/20 0.41
CCNT1 O60563 2/20 0.40
CDK9 P50750 2/20 0.40
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
ALDH1A1 P00352 2/20 0.38
LMNA P02545 1/20 0.38
HPGD P15428 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4926630 0.85 CSF1R (0.43) PTGER1GABRG2GABRB3GABRA5GABRA1
SCHEMBL4158329 0.80 PTGER1 (0.42) PTGER1GABRG2GABRB3GABRA5GABRA1
SCHEMBL4154318 0.80 PTGER1 (0.42) PTGER1GABRG2GABRB3GABRA5GABRA1
SCHEMBL4148470 0.80 PTGER1 (0.43) PTGER1CYP2C9MEN1KMT2AALDH1A1
SCHEMBL4924658 0.78 CSF1R (0.42) PTGER1GABRG2GABRB3GABRA5GABRA1
SCHEMBL4155131 0.78 PTGER1 (0.54) PTGER1GABRA2GABRB2CYP2C9MEN1
SCHEMBL5619619 0.78 PTGER1 (0.45) PTGER1CYP2C9MEN1KMT2AALDH1A1
SCHEMBL4918882 0.76 PTGER1 (0.45) PTGER1CYP2C9MEN1KMT2AALDH1A1
SCHEMBL4914240 0.76 PTGER1 (0.51) PTGER1GABRA2GABRB2CYP2C9MEN1
SCHEMBL4922991 0.74 GABRG2 (0.43) PTGER1GABRG2GABRB3GABRA5GABRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090227591-A1 Cyclopentene compounds GLAXO GROUP LIMITED (GB) 2009-09-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090227591-A1 Cyclopentene compounds C1R, CYP1B1, ADORA2B PTGER1 246/4885GABRG2 2702/4885GABRB3 1196/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.